Navigation Links
Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2
Date:10/6/2008


- Hydresia(TM) G2 approved by leading European authority on natural/

organic certification -

TSX symbol: SBS

CALGARY, Oct. 6 /PRNewswire-FirstCall/ - Botaneco Specialty Ingredients Inc. (Botaneco), a subsidiary of SemBioSys Genetics Inc. (SemBioSys), today announced that its second generation oleosome product, Hydresia(TM) G2, has been authorized by ECOCERT(R) as an approved raw material, complying with the standards for ecological and organic cosmetics. ECOCERT(R) is one of the largest organic control and certification organizations in the world and conducts inspections in over 80 countries. The company's primary focus is food and food products, cosmetics, detergents, perfumes, and textiles.

"Botaneco is dedicated to manufacturing its all-natural products to comply with the highest natural production standards while eliminating the use of chemicals and synthetics," said Andrew Baum, president and CEO of Botaneco's parent company, SemBioSys. "The ECOCERT(R) authorization validates our product and production process with the most internationally recognized symbol for natural and organic raw materials."

Hydresia(TM) G2 is a cold-process emulsifying system comprised of oleosomes, naturally occurring oil reservoirs derived from safflower seeds. Oleosomes are nature's warehouse, or storage facility, for the emollient oils, antioxidants and natural moisture barriers that serve to keep the skin soft, supple and young looking. Using a proprietary non-solvent aqueous extraction process, these oleosomes are isolated from the seed fully intact, and when used in skin care applications can provide lasting protection to the skin. Hydresia(TM) G2 is a natural, renewable replacement for hydrocarbon derived petrolatum, mineral oil and non-ionic surfactants.

About Botaneco Specialty Ingredients Inc.

Botaneco is the global developer and marketer of innovative oleosome-based ingredients to the personal care and OTC topical
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Botaneco obtains $2.4 million in funding from AVAC
2. Botaneco Announces Launch of Second Generation Oleosome Product
3. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
4. Botaneco announces $4,000,000 financing
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
9. IsoTis Receives FDA Clearance for Accell Family of Products
10. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... full service biopharmaceutical contract development and manufacturing organization ... by Progenics Pharmaceuticals, Inc., an oncology company focused ... and treating cancer, to manufacture the anti-prostate specific ... PSMA ADC product candidate. Under the agreement ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Livermore, California (PRWEB) August 20, 2014 ... to develop and apply the most complete climate ... challenging and demanding climate change issues. , Eight ... combining forces with the National Center for Atmospheric ... in the new effort. Other participating national laboratories ...
(Date:8/20/2014)... Not long ago, it was more ... performed late in the development cycle – even after ... trends suggest that, like many things GxP, expectations for ... years, multiple drug sponsors have been required by authorities ... during phase I/II. It’s not only clinical trial material ...
Breaking Biology Technology:Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... be allowed to tax Internet usage, in a move that ... hole in the state budget. , ,The federal measure to ... , R-Wis., who said home users could save around a ... Tax Nondiscrimination Act, a tech-neutral plan that exempts all Internet ...
... Dark Ages, where marks were burned onto cattle. On ever-so-slowly-evolving minds ... solid impression and provides a daily dose of comfort. Belonging to ... a security blanket. A warm fuzzy feeling when a huge name ... craves to carry something with a logo, color and stripes, wear ...
... Wis. The North Carolina simulated learning company ... the Croquet Project at UW-Madison, a graphical communications ... trade show in Orlando that it has begun developing software ... applied to military and commercial avenues. , ,What were doing ...
Cached Biology Technology:State faces revenue drop as federal Internet tax ban passes House 2The black hole of corporate branding 2The black hole of corporate branding 3The black hole of corporate branding 4UW open-source 3D environment tapped for commercial development 2
(Date:8/20/2014)... therapy developed by researchers at the University of Missouri ... from a life-threatening heart condition caused by muscular dystrophy. ... Yi Lai, Ph.D., the leading author of the study ... Medicine,s Department of Molecular Microbiology and Immunology. "This is ... lead to a treatment for people with this devastating ...
(Date:8/20/2014)... 1 (PS1) absorbs light and its energy is ... to biomass. Photovoltaic devices, mostly build from silicon ... electricity. One approach for the development of cheaper ... with the isolated membrane protein complexes of photosynthesis. ... stable PS1 from thermophilic cyanobacteria that live in ...
(Date:8/19/2014)... to decrease China,s increasing caesarean section rate, suggests a ... An International Journal of Obstetrics and Gynaecology (BJOG) . ... rates in the world. Of 16 million babies born ... exact rate is not known, the current Chinese language ... rates ranging from 36% to 58%. However, before the ...
Breaking Biology News(10 mins):Gene therapy protects mice from lethal heart condition, MU researchers find 2A semi-artificial leaf faster than 'natural' photosynthesis 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3
... urine test for prostate cancer that measures minute fragments ... through the University of Michigan MLabs. The new testMi-Prostate ... increases physicians, ability to pick out high-risk prostate tumors ... of thousands of men avoid unnecessary biopsies. The ...
... 2013 MedNet Solutions , a global life ... is pleased to announce that Accelovance , an ... phase Oncology, Vaccines and General Medicine development, has joined ... .    Designation as an iMedNet Partner will ...
... the first ever interior 3D map of Italy,s iconic Leaning ... system. Developed by the CSIRO, Australia,s national science agency, ... a laser scanner that sways on a spring to capture ... an operator can walk through it. Specialised software then converts ...
Cached Biology News:Prostate Cancer Foundation announces new urine test for prostate cancer available 2Prostate Cancer Foundation announces new urine test for prostate cancer available 3MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 33D mapping is a 'Pisa' cake for Aussie scientists 2
... software, PC, is used to perform ... obtained from the Experion automated electrophoresis ... electropherogram and simulated gel views and ... in a Results table. This software ...
... use in the Microsart e.motion are sterile-sealed, without ... a specially designed individual package on a band. ... of membrane filter units ensures that they are ... sealed band guarantees uniform dispensing of the individual ...
... that will help protect your PCR runs ... work area prior to use, reducing the ... Containment features reduce the chance of airborne ... for a clear view, an acid-resistant black ...
...
Biology Products: